ESR1 and breast cancer: Tamoxifen is widely and effectively used to treat ERα-positive breast cancer with tolerable toxicity29, and no acute toxicity for tamoxifen monotherapy or in combination with EZH2i or CDK2i was observed using the doses we have chosen.